Search for: "RISING PHARMACEUTICALS, INC."
Results 401 - 420
of 462
Sort by Relevance
|
Sort by Date
27 Mar 2009, 7:20 am
(Technology Transfer Tactics) Global - Trade Marks / Brands Starfish and spiders – trade mark hazards for decentralised, non-hierarchical organisations (Property, intangible) Global - Patents Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Agreement to simplify international patent classification system (WIPO) (IPKat) (Competitive Info) Concerns voiced at WIPO over potential… [read post]
27 Mar 2009, 5:15 am
(In the Arkansas Prempro MDL, which consists of thousands of cases, the judge has ordered the plaintiffs to complete discovery involving defendants Pfizer Inc. and Wyeth Pharmaceuticals Inc. by Sept. 1 , 2009) . [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360) Global - Copyright Expanding the public domain: part zero (Creative Commons) Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian Trade… [read post]
14 Feb 2009, 11:56 am
Class Action Practice Is on the Rise Across Many Sectors Class actions in federal court have risen steadily in recent years, increasing 72% between 2001 and 2007 and averaging 4,000-5,000 per year as of mid-2007. [read post]
11 Feb 2009, 1:55 pm
The agency sent letters to 16 manufacturers of 24 products including Purdue Pharma LP, the maker of OxyContin, which is available in an extended-release form; a unit of Johnson & Johnson that makes a fentanyl patch; and King Pharmaceuticals Inc., the maker of an extended-release form of morphine. [read post]
3 Feb 2009, 4:23 am
Pfizer, Inc., Docket Nos. 05-4863-cv (L), 05-6768-cv (CON), slip op. (2d Cir. [read post]
3 Feb 2009, 1:40 am
JPMorgan Chase & Co., Bank of America Corp., Barclays Plc, Citigroup Inc. and Goldman Sachs Group Inc. assembled the loan package for Pfizer. [read post]
25 Jan 2009, 2:36 pm
Morgan Stanley and Evercore Partners Inc. are counseling Wyeth, the people said. [read post]
13 Jan 2009, 4:05 am
Inspire Pharmaceuticals Inc., 549 F.3d 618 (4th Cir. 2008) [Slip Opn., at 2]. [read post]
8 Jan 2009, 12:32 pm
First DataBank, Inc., 244 F.R.D. 79 (D. [read post]
23 Dec 2008, 7:00 pm
It was withdrawn at Par Pharmaceuticals based on the Board of Directors' commitment to adopt the policy in 2009. [read post]
13 Nov 2008, 1:52 pm
Yuba Power Products, Inc., explained the rationale for what it called "strict liability":We need not recanvass the reasons for imposing strict liability on the manufacturer. [read post]
21 Oct 2008, 8:15 pm
Merrell Dow Pharmaceuticals seems to break down as well. [read post]
20 Oct 2008, 10:23 am
Investors have to prove that their losses were because of managerial fraud and not a result of the ordinary fluctuations in the market.[23] Recently two major Supreme Court decisions have made it even more difficult for investors to bring fraud claims against corporate executives.[24] The first obstacle comes from a 2005 ruling.[25] The Supreme Court held that alleging a director's general misrepresentation caused inflated share prices and therefore loss to… [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
14 Aug 2008, 10:55 am
Rising Pharmaceuticals, Inc., --- F.Supp.2d ----, 2008 WL 3287932 (E.D.N.Y.) [read post]
9 Aug 2008, 1:50 am
: (Patenting Lives), Worldwide increase in patent filings puts strain on system: (Managing Intellectual Property), WIPO releases 2008 Worldwide Patent Report: (Peter Zura's 271 Patent Blog), (Patent Prospector), (IP Updates), Global patent filings continue rise but may level off; smaller nationals slipping: (Intellectual Property Watch), Means plus function: Don’t ignore the man behind the curtain: (Intellectual Property Directions), Technology start-up entrepreneurs and… [read post]
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
